MMP13 promotes the osteogenic potential of BMP9 by enhancing Wnt/β-catenin signaling via HIF-1α upregulation in mouse embryonic fibroblasts
The International Journal of Biochemistry & Cell Biology · 2023
DOI: 10.1016/j.biocel.2023.106476 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2023. Verfasst von Yue Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of pharmacology, School of Pharmacy, Chongqing Medical University, Chongqing 400016, People's Republic of China; Key Laboratory of Biochem…. Hauptthemen laut MEDLINE: beta Catenin, Growth Differentiation Factor 2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Bone morphogenetic protein 9 (BMP9) has been validated as one of the most potent osteoinduction factors, but its underlying mechanism remains unclear. As a member of the matrix metalloproteinase (MMP) family, MMP13 may be involved in regulating the lineage-specific differentiation of mouse embryonic fibroblasts (MEFs). The goal of this study was to determine whether MMP13 regulates the osteoinduction potential of BMP9 in MEFs, which are multipotent progenitor cells widely used for stem cell biology research. In vitro and in vivo experiments showed that BMP9-induced osteogenic markers and/or bone were enhanced by exogenous MMP13 in MEFs, but were reduced by MMP13 knockdown or inhibition. The expression of hypoxia inducible factor 1 alpha (HIF-1α) was induced by BMP9, which was enhanced by MMP13. The protein expression of β-catenin and phosphorylation level of glycogen synthase kinase-3 beta (GSK-3β) were increased by BMP9 in MEFs, as was the translocation of β-catenin from the cytoplasm to the nucleus; all these effects of BMP9 were enhanced by MMP13. Furthermore, the MMP13 effects of increasing BMP9-induced β-catenin protein expression and GSK-3β phosphorylation level were partially reversed by HIF-1α knockdown. These results suggest that MMP13 can enhance the osteoinduction potential of BMP9, which may be mediated, at least in part, through the HIF-1α/β-catenin axis. Our findings demonstrate a novel role of MMP13 in the lineage decision of progenitor cells and provide a promising strategy to speed up bone regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of pharmacology, School of Pharmacy, Chongqing Medical University, Chongqing 400016, People's Republic of China; Key Laboratory of Biochemistry and Molecular Pharmacology of Chongqing, Chongqing Medical Unive…
Zitieren
APA
Jiang, Y., Liu, L., Deng, Y. X., Zhang, J., Ye, A. H., Ye, F. L., & He, B. C. (2023). MMP13 promotes the osteogenic potential of BMP9 by enhancing Wnt/β-catenin signaling via HIF-1α upregulation in mouse embryonic fibroblasts. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2023.106476
Vancouver
Jiang Y, Liu L, Deng YX, Zhang J, Ye AH, Ye FL, et al. MMP13 promotes the osteogenic potential of BMP9 by enhancing Wnt/β-catenin signaling via HIF-1α upregulation in mouse embryonic fibroblasts. The International Journal of Biochemistry & Cell Biology. 2023. doi:10.1016/j.biocel.2023.106476
BibTeX
@article{Jiang2023,
author = {Jiang, Yue and Liu, Lu and Deng, Yi-Xuan and Zhang, Jie and Ye, Ai-Hua and Ye, Fang-Lin and He, Bai-Cheng},
title = {MMP13 promotes the osteogenic potential of BMP9 by enhancing Wnt/β-catenin signaling via HIF-1α upregulation in mouse embryonic fibroblasts},
journal = {The International Journal of Biochemistry & Cell Biology},
year = {2023},
doi = {10.1016/j.biocel.2023.106476}
}
EUVIMED